Xile Zhou

688 total citations · 1 hit paper
21 papers, 424 citations indexed

About

Xile Zhou is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Xile Zhou has authored 21 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 9 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Xile Zhou's work include Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Xile Zhou is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Organ Transplantation Techniques and Outcomes (4 papers). Xile Zhou collaborates with scholars based in China, Madagascar and Taiwan. Xile Zhou's co-authors include Guosheng Wu, Wenguang He, Weiqin Jiang, Yinjun He, Hanju Hua, Weixiang Zhong, Yongfeng Ding, Lu Qi, Qinsong Sheng and Yimin Lu and has published in prestigious journals such as Annals of Surgery, Journal of Hepatology and Frontiers in Immunology.

In The Last Decade

Xile Zhou

19 papers receiving 420 citations

Hit Papers

Exhausted CD8+T Cells in the Tumor Immune Microenvironmen... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xile Zhou China 7 212 193 163 76 57 21 424
Tianxiao Xu China 14 255 1.2× 294 1.5× 107 0.7× 110 1.4× 68 1.2× 29 506
Chunyi Shen China 12 232 1.1× 263 1.4× 190 1.2× 149 2.0× 91 1.6× 17 533
Barbara Montico Italy 10 146 0.7× 129 0.7× 166 1.0× 52 0.7× 37 0.6× 19 345
Daniel F. Camacho United States 9 168 0.8× 155 0.8× 85 0.5× 80 1.1× 93 1.6× 11 396
Dmitrij Ostroumov Germany 5 337 1.6× 137 0.7× 294 1.8× 63 0.8× 60 1.1× 6 526
Hans Anton Schloesser Germany 5 247 1.2× 136 0.7× 168 1.0× 54 0.7× 89 1.6× 11 438
Sabrina Carpentier France 9 225 1.1× 128 0.7× 372 2.3× 89 1.2× 69 1.2× 11 573
Gesa Schuebbe Germany 3 239 1.1× 147 0.8× 163 1.0× 54 0.7× 95 1.7× 6 445
Zhengtao Hong China 7 239 1.1× 142 0.7× 222 1.4× 56 0.7× 82 1.4× 9 458
Tanja Grimmig Germany 10 178 0.8× 134 0.7× 173 1.1× 94 1.2× 37 0.6× 19 427

Countries citing papers authored by Xile Zhou

Since Specialization
Citations

This map shows the geographic impact of Xile Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xile Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xile Zhou more than expected).

Fields of papers citing papers by Xile Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xile Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xile Zhou. The network helps show where Xile Zhou may publish in the future.

Co-authorship network of co-authors of Xile Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Xile Zhou. A scholar is included among the top collaborators of Xile Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xile Zhou. Xile Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Yinjun, Xiang Zhang, Wenguang He, et al.. (2025). Optimization of Immunotherapy Strategies Based on Spatiotemporal Heterogeneity of Tumour‐Associated Tissue‐Resident Memory T Cells. Immunology. 175(2). 123–133. 1 indexed citations
2.
Jiang, Beibei, Xiang Zhang, Wenguang He, et al.. (2025). The prognostic and predictive value of homologous recombination deficiency in gastrointestinal cancer. The Oncologist. 30(6). 3 indexed citations
3.
Zhang, Xiang, Yinjun He, Wenguang He, et al.. (2024). Reclassification of RAS/BRAF allele mutations predicts the survival benefit of triplet chemotherapy in metastatic colorectal cancer. Therapeutic Advances in Medical Oncology. 16. 2669771–2669771.
4.
Zhou, Xile, Yang Ji, & Jinming Zhou. (2023). Multiple Strategies to Develop Small Molecular KRAS Directly Bound Inhibitors. Molecules. 28(8). 3615–3615. 11 indexed citations
5.
Wu, Guosheng, Long Zhao, Weiqin Jiang, et al.. (2023). Intestinal Autotransplantation for Locally Advanced or Locally Recurrent Colon Cancer Invading Superior Mesenteric Artery. Annals of Surgery. 281(3). 462–468. 2 indexed citations
6.
He, Yinjun, Xiang Zhang, Ming Zhu, et al.. (2023). Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer. Journal of Translational Medicine. 21(1). 46–46. 25 indexed citations
8.
Jiang, Weiqin, Yinjun He, Wenguang He, et al.. (2023). Metastatic sites and lesion numbers cooperated to predict efficacy of PD‐1 inhibitor‐based combination therapy for patients with metastatic colorectal cancer. Cancer Medicine. 12(11). 12482–12494. 1 indexed citations
10.
Hua, Hanju, Wenguang He, Nan Chen, et al.. (2023). Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy. Frontiers in Immunology. 13. 974793–974793. 9 indexed citations
11.
Wu, Guosheng, Chaoxu Liu, Xile Zhou, et al.. (2022). Short- and long-term complications after living donor ileal resection. American Journal of Transplantation. 22(12). 3053–3060. 4 indexed citations
12.
Wang, Shujie, Ning Zhang, Zixiong Zhang, et al.. (2022). A High Throughput Cell-Based Screen Assay for LINE-1 ORF1p Expression Inhibitors Using the In-Cell Western Technique. Frontiers in Pharmacology. 13. 881938–881938. 1 indexed citations
14.
Wu, Guosheng, Chaoxu Liu, Nan Ma, et al.. (2022). Successful combined auxiliary partial liver and intestinal transplantation in two highly sensitized, cross‐match positive patients. Clinical Transplantation. 37(3). e14865–e14865. 1 indexed citations
15.
Jiang, Weiqin, Yinjun He, Wenguang He, et al.. (2021). Exhausted CD8+T Cells in the Tumor Immune Microenvironment: New Pathways to Therapy. Frontiers in Immunology. 11. 622509–622509. 225 indexed citations breakdown →
16.
Wang, Qian, Ning Liang, Tao Yang, et al.. (2021). DNMT1-mediated methylation of BEX1 regulates stemness and tumorigenicity in liver cancer. Journal of Hepatology. 75(5). 1142–1153. 102 indexed citations
17.
Zhou, Xile, et al.. (2019). Surgical repair of traumatic cloaca: a modified technique. Colorectal Disease. 21(10). 1206–1210. 1 indexed citations
18.
Liang, Wenjie, et al.. (2010). Air Bronchogram Sign in Primary Pulmonary T-Cell Lymphoma with Multiple Nodules. Iranian Journal of Radiology. 7(2). 105–108. 1 indexed citations
19.
Xie, Rong, et al.. (1999). [CT in diagnosis of tuberculosis of liver and spleen].. PubMed. 22(4). 237–8. 5 indexed citations
20.
H, Shi, Rong He, & Xile Zhou. (1997). [Molecular biology studies on metalloproteinase and tissue inhibitor of metalloproteinase expression in salivary adenoid cystic carcinoma].. PubMed. 32(6). 323–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026